20
Participants
Start Date
September 23, 2015
Primary Completion Date
August 20, 2018
Study Completion Date
August 20, 2018
Everolimus
10 mg tablets
Fox Chase Cancer Center, Philadelphia
Yale School of Medicine, New Haven
Dana Farber Cancer Institute, Boston
Mayo Clinic, Rochester
Memorial Sloan Kettering, New York
Duke University Health System, Durham
University of Pennsylvania, Philadelphia
M D Anderson Cancer Center, Houston
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Fox Chase Cancer Center
OTHER